Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Exercise × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 122 Gastrointestinal 59 Genitourinary 38 Other hematologic neoplasm 30 Lymphoid 28 Other 24 Thoracic 23 Gynecologic 17 Tumor-Agnostic 12 Head & Neck 11 CNS 10 Plasma cell 9 Dermatologic 4 Endocrine 3 Sarcoma 2 Other solid neoplasm 2 Myeloid 2 Other neoplasm 1 Classical hematology 1

Conditions

Myelodysplastic Syndromes 1 Cytopenia 1

Interventions

Cyclophosphamide 81 fludarabine phosphate 73 Busulfan 53 Cyclosporine 51 Epoetin Alfa 48 Whole-Body Irradiation 47 Mycophenolic Acid 45 Peripheral Blood Stem Cell Transplantation 43 fludarabine 39 Melphalan 35 Cytarabine 35 Filgrastim 34 Darbepoetin alfa 34 Antilymphocyte Serum 34 Tacrolimus 31 Methotrexate 27 Radiotherapy 26 Cord Blood Stem Cell Transplantation 25 Granulocyte Colony-Stimulating Factor 20 Methylprednisolone 19 Rivaroxaban 18 Etoposide 18 apixaban 17 eltrombopag 15 Dalteparin 14 Azacitidine 14 Alemtuzumab 14 ferric carboxymaltose 13 epoetin beta 13 Thiotepa 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06773871 2025-08-19

HemEx

Rigshospitalet, Denmark

Phase NA Recruiting

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡